Literature DB >> 8692479

Radiochemical and radioimmunological data of 99Tcm-anti-CEA labelled by two diverse methods.

A D Varvarigou1, S C Archimandritis, K Sekeri-Pataryas, T G Sourlingas, G Sivolapenko, E Paschali.   

Abstract

The aim of this study was to make a comparative evaluation of a direct and an indirect method for the labelling of anti-CEA with technetium-99m (99Tcm). With the direct method, disulphide bridges were cleaved by the use of 2-mercaptoethanol as reductant, whereas with the indirect method, the antibody was coupled to 2-iminothiolane. In both cases, a preformed intermediate chelate was used for 99Tcm exchange. The radiochemical and radiobiological behaviour of the 99Tcm-labelled species were studied. Furthermore, the influence of the labelling systems on the integrity of monoclonal antibodies, as well as the ability of 99Tcm-anti-CEA to tag onto human cancer cells, was investigated for the two labelling systems. Both methods showed a high labelling yield and resulted in immunoreactive and stable derivatives. However, detailed electrophoretical and radiochemical data, as well as the cysteine challenge trial, indicated relatively greater stability for the 2-mercaptoethanol reduction procedure.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8692479     DOI: 10.1097/00006231-199601000-00014

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  2 in total

1.  Technetium-99m labelling of human immunoglobulin and preliminary clinical evaluation in tumour patients.

Authors:  A D Varvarigou; S C Archimandritis; A Stripsanelli; A Arka; P Kostamis
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1998 Apr-Jun       Impact factor: 2.441

2.  A Novel Metal-Based Imaging Probe for Targeted Dual-Modality SPECT/MR Imaging of Angiogenesis.

Authors:  Charalampos Tsoukalas; Dimitrios Psimadas; George A Kastis; Vassilis Koutoulidis; Adrian L Harris; Maria Paravatou-Petsotas; Maria Karageorgou; Lars R Furenlid; Lia A Moulopoulos; Dimosthenis Stamopoulos; Penelope Bouziotis
Journal:  Front Chem       Date:  2018-06-20       Impact factor: 5.221

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.